Graf Akcie ATRS (Antares Pharma Inc). Diskuze k akciím ATRS. Aktuální informace ATRS.

Základní informace o společnosti Antares Pharma Inc (Akcie ATRS)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 582.35M
Hodnota podniku (EV) 609.91M
Tržby 171.197M
EBITDA 27.436M
Zisk 64.595M
Růst v tržbách Q/Q 38.89 %
Růst v tržbách Y/Y 24.41 %
P/E (Cena vůči ziskům) 8.85
Forward P/E 0.06
EV/Sales 3.56
EV/EBITDA 22.23
EV/EBIT 25.51
PEG 0.35
Price/Sales 3.39
P/FCF 52.20
Price/Book 4.87
Účetní hodnota na akcii 0.71
Hotovost na akcii 0.32
FCF vůči ceně 1.92 %
Počet zaměstnanců 185
Tržba na zaměstnance 925.389k
Profit margin 37.57 %
Operating margin 24.55 %
Gross margin 63.93 %
EBIT margin 13.96 %
EBITDA margin 16.03 %
EPS - Zisk na akcii 0.39
EPS - Kvartální růst 200.00 %
EPS - Očekávaný růst příští rok 0.00 %
Return on assets 32.33 %
Return on equity 58.38 %
ROIC 7.94 %
ROCE 17.00 %
Dluhy/Equity 0.78
Čistý dluh/EBITDA -1.27
Current ratio 1.78
Quick Ratio 1.52
Volatilita 3.16
Beta 1.13
RSI 38.99
Cílová cena analytiků 6
Známka akcie (dle analytiků) N/A
Insider ownership 2.15 %
Institutional ownership 50.06 %
Počet akcií 169.968M
Procento shortovaných akcií 2.53 %
Short ratio 6.29 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2012
Země United States

Finanční výsledky akcie ATRS

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$123.864$63.554$54.515$52.222$45.658$26.502
Cost Of Goods Sold$50.475$31.065$27.466$28.817$19.458$11.237
Gross Profit$73.389$32.489$27.049$23.405$26.2$15.265
Research And Development Expenses$10.624$12.328$11.854$19.592$19.731$18.638
SG&A Expenses$61.773$36.762$31.646$27.93$26.931$31.74
Other Operating Income Or Expenses-$12.5$0.86---
Operating Expenses$122.872$67.655$70.106$76.339$66.12$61.615
Operating Income$0.992$-4.101$-15.591$-24.117$-20.462$-35.113
Total Non-Operating Income/Expense$-3.019$-2.414$-1.152$-0.122$-0.022$-0.013
Pre-Tax Income$-2.027$-6.515$-16.743$-24.239$-20.484$-35.127
Income Taxes---$0.1$0.175$0.025
Income After Taxes$-2.027$-6.515$-16.743$-24.339$-20.659$-35.152
Other Income------
Income From Continuous Operations$-2.027$-6.515$-16.743$-24.339$-20.659$-35.152
Income From Discontinued Operations------
Net Income$-2.027$-6.515$-16.743$-24.339$-20.659$-35.152
EBITDA$3.549$-1.377$-13.487$-22.256$-18.882$-33.869
EBIT$0.992$-4.101$-15.591$-24.117$-20.462$-35.113
Basic Shares Outstanding163157156155147131
Shares Outstanding163157156155147131
Basic EPS$-0.01$-0.04$-0.11$-0.16$-0.14$-0.27
EPS - Earnings Per Share$-0.01$-0.04$-0.11$-0.16$-0.14$-0.27
# 2020 2019 2018 2017 2016 2015
Current Ratio3.34562.62233.52992.27383.92762.2139
Long-term Debt / Capital0.42570.36150.4256---
Debt/Equity Ratio0.74120.64420.741---
Gross Margin59.249751.120349.617544.818357.383257.6
Operating Margin0.8009-6.4528-28.5995-46.1817-44.8158-132.4947
EBIT Margin0.8009-6.4528-28.5995-46.1817-44.8158-132.4947
EBITDA Margin2.8652-2.1667-24.74-42.6181-41.3553-127.7997
Pre-Tax Profit Margin-1.6365-10.2511-30.7127-46.4153-44.864-132.5453
Net Profit Margin-1.6365-10.2511-30.7127-46.6068-45.2473-132.6396
Asset Turnover0.93310.71990.73330.78740.53990.3854
Inventory Turnover Ratio3.15472.7372.96135.40963.39911.9176
Receiveable Turnover3.53153.34924.58965.75585.74147.5502
Days Sales In Receivables103.3554108.98279.52863.414863.573848.343
ROE - Return On Equity-3.7193-16.7047-49.9091-53.8259-30.8147-85.3277
Return On Tangible Equity-3.8298-17.5725-53.921-57.8426-32.5273-94.4538
ROA - Return On Assets-1.5269-7.3802-22.5228-36.6966-24.4305-51.1129
ROI - Return On Investment-2.136-10.6656-28.6671-53.8259-30.8147-85.3277
Book Value Per Share0.32990.24420.21410.29140.4330.3127
Operating Cash Flow Per Share0.04470.038-0.050.09440.0093-0.0837
Free Cash Flow Per Share0.01880.0755-0.01380.10140.0065-0.0978